Sulphate metabolism
in autism
|
|
This is a complex subject in which the sulphate ion can be
both produced in the body through biochemical formation (generally from methionine and cysteine aminoacids) and absorbed from the gut.
It is transported across membranes by various transporter protein molecules, which are found almost
universally in the body. The ion is
activated into PAPS (adenosine 3’-phosphate 5’-sulphatophosphate) which is a
donor molecule to cause the sulphation through the
formation of an ester.
This causes the formation of highly soluble molecules that
are good for urinary or biliary elimination. The body also forms heparans
and glycans using PAPS in a complex method.
In the gut sulphate is absorbed in the small intestine
through deliberate transporter molecules, about
which little is known concerning their regulation. In an adult the whole body inorganic
sulphate turnover is represented by the 841 +/- 49 micromol/hr and average urinary inorganic sulphate
excretion is around 600 micromol/hr. Following
injection of sulphate into the body around 50% is excreted as esters and
whole body sulphation accounted for around 27% of inorganic
sulphate turnover. Exracellular
inorganic sulphate is an important pool for intracellular sulphation.
It should be noted that sulphate, because of its
interaction with cysteine and methionine
formation must be viewed with the formation of other sulphur containing
compounds e.g. glutathione and oxidative stress
We do know that these compounds (like heparin, and chondroitin sulphate, and the glycosaminoglycans
that are present in large amounts in the basal membranes of the gut, kidney
and skin) may well be modified but the research in this respect is missing
from major literature.
|

Glycosaminoglycans
are long chains of sugar molecules with sulphate modification of some of the
ester linked elements. They can be
variants and vary dramatically in the amount of sulphate depending on the
amount of sulphate available when they are being made.
|
Normal
sulphate biology
It is probably a good idea to read through one of these
simply to get a grip on how sulphates are formed, taken in from the gut, and
excreted. They may also be created
through specific biological mechanisms that are altered in ASD.
Markovich D. Physiological role and
regulation of mammalian sulfate transporters. Physiological reviews. 2001;81:1499-1533. also see: Cole D, Evrosvski
J. The clinical
chemistry of inorganic sulfate. Crit Rev Clin Lab Sci 2000 37(4);299-44. Also see: Hoffer LJ et al. Human sulfate kinetics. Am J Physiol Regul Integr Comp Physiol 2005;289;R1372-80.
Hoffer LJ, Hamadeh MJ, Robitaille L, Norwich
KH. Human sulfate
kinetics. Am J Physiol Regul
Integr Comp Physiol. 2005
Nov;289(5):R1372-80. Epub 2005 Jul 28.
Cole
DE, Evrovski J. The
clinical chemistry of inorganic sulfate. Crit Rev Clin Lab Sci. 2000 Aug;37(4):299-344.
Alterations
seen in autism
McFadden
SA.Toxicology.
Phenotypic variation
in xenobiotic metabolism and adverse environmental
response: focus on sulfur-dependent detoxification
pathways. 1996 Jul 17;111(1-3):43-65. (autism only used as
an example in the impaired sulphation of xenobiotic compounds)
Alberti
A, Pirrone P, Elia M, Waring RH, Romano C. Sulphation deficit in
"low-functioning" autistic children: a pilot study. Biol
Psychiatry. 1999 Aug 1;46(3):420-4. (also found low levels of sulphotransferase
in platelets and low plasma sulphate).
Urinary
increased sulphate (inorganic, organic), sulphite, thiocyanite (by about 50%) in autism vs control. Also d-glucaric acid was very high, which is also used as a
modifier for toxins. Original source is
not clear. This is quoted under Adams work, who is clearly
wanting to press ahead with sulphate research.
Waring RH, Klovrza
LV. Sulphur
metabolism in autism. J Nutritional
and Environmental Medicine 2000;1:25-32 (Urinary
excretion of sulphate sulphate, thiocyanate
and thiosulphate were measured in 232 autistic
children and compared with 68 controls.
Significantly higher excretion was seen in all of these compounds except
thiocyanate).
Metabolic biomarkers of increased
oxidative stress and impaired methylation capacity in
children with autism. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Am J Clin Nutr.
2004 Dec;80(6):1611-7.
Relative to the control children, the
children with autism had significantly lower baseline plasma concentrations of methionine, SAM, homocysteine, cystathionine, cysteine, and
total glutathione and significantly higher concentrations of SAH, adenosine,
and oxidized glutathione. This metabolic profile is consistent with impaired
capacity for methylation (significantly lower ratio
of SAM to SAH) and increased oxidative stress (significantly lower redox ratio of reduced glutathione to oxidized glutathione)
in children with autism. The intervention trial was effective in normalizing
the metabolic imbalance in the autistic children.
Geier DA, Geier MR. A
clinical and laboratory evaluation of methionine
cycle-transsulfuration and androgen pathway
markers in children with autistic disorders. Horm
Res. 2006;66(4):182-8. (this
has been followed up by several groups but nobody has found the reason or
prevalence behind it. The effect it would have on the
androgen pathways is also unclear)
Waring RH, Ngong JM, Klovrza L, Green S, Sharp H. Biochemical parameters in autistic children. Dev Brain Dystunction
1997;10:40-43.
(a short review, particularly showing the
changes in autism)
Geier DA, Kern JK, Garver
CR, Adams JB, Audhya T, Geier
MR. A Prospective Study of Transsulfuration
Biomarkers in Autistic Disorders. Neurochem Res. 2008 Jul 9. (Participants diagnosed with ASDs had significantly (P < 0.001) decreased plasma
reduced glutathione, plasma cysteine, plasma taurine, plasma sulfate, and
plasma free sulfate relative to controls. By
contrast, participants diagnosed with ASDs had
significantly (P < 0.001) increased plasma oxidised glutathione relative to
controls.. Full
article at: A prospective study of transsulfuration
biomarkers in autistic disorders. Geier
DA, Kern JK, Garver CR, Adams JB, Audhya
T, Geier MR. Neurochem Res.
2009 Feb;34(2):386-93. Epub 2008 Jul 9. Erratum in: Neurochem Res. 2009 Feb;34(2):394
Metabolic endophenotype and
related genotypes are associated with oxidative stress in children with autism.
James SJ, Melnyk S, Jernigan S, Cleves
MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M,
Bradstreet JJ, Baker SM, Gaylor DW. Am J Med Genet B Neuropsychiatr Genet.
2006 Dec 5;141B(8):947-56 Plasma levels of metabolites in methionine transmethylation and transsulfuration pathways were measured in 80 autistic and
73 control children. In addition, common polymorphic variants known to modulate
these metabolic pathways were evaluated in 360 autistic children and 205
controls. The metabolic results indicated that plasma methionine
and the ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH), an indicator of methylation capacity, were significantly decreased in the
autistic children relative to age-matched controls. In addition, plasma levels
of cysteine, glutathione, and the ratio of reduced to
oxidized glutathione, an indication of antioxidant capacity and redox homeostasis, were significantly decreased. The group is putting these over as
potentially being associated with genetic changes but they are not carrying out
the isolation of the isolation of the genes past some specific ones. Differences in allele frequency and/or
significant gene-gene interactions were found for relevant genes encoding the
reduced folate carrier (RFC 80G > A), transcobalamin II (TCN2 776G > C), catechol-O-methyltransferase
(COMT 472G > A), methylenetetrahydrofolate reductase (MTHFR 677C > T and 1298A > C), and
glutathione-S-transferase (GST M1).
One Carbon Metabolism Disturbances
and the C667T MTHFR Gene Polymorphism in Children with Autism Spectrum
Disorders. Paşca SP, Dronca E, Kaucsár T, Craciun EC, Endreffy E, Ferencz BK, Iftene F, Benga I, Cornean R, Banerjee R, Dronca M. J Cell Mol
Med. 2008 Aug 9. This is an attempt to
see if there is an association between the genes of the trans-sulfuration pathways, and various other pathways involving
B12, and methionine cycle may be altered in children
with ASD. No metabolic disturbances
were seen in the Aspergers patients, while in the
autistic and PDD-NOS groups, lower plasma levels of methionine
(P=0.01 and P=0.03, respectively) and alpha-aminobutyrate
were observed (P=0.01 and P=0.001, respectively). Only in the autistic group,
plasma cysteine (P=0.02) and total blood glutathione
(P=0.02) were found to be reduced. They
did not find a statistical difference in the genetics of the cases but felt
that a change in the one carbon metabolism may have altered.
Efficacy of methylcobalamin
and folinic acid treatment on glutathione redox status in children with autism.
James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW. Am J Clin Nutr. 2009 Jan;89(1):425-30. The results indicated that pretreatment metabolite concentrations in autistic children
were significantly different from values in the control children. The 3-mo intervention with methyl cobalamine
and folinic acid resulted in significant increases in
cysteine, cysteinylglycine,
and glutathione concentrations (P < 0.001). The significant improvements observed in transmethylation metabolites and glutathione redox status after treatment suggest that targeted
nutritional intervention with methylcobalamin and folinic acid may be of clinical benefit in some children
who have autism. In other words they
also found a difference in the ability of the child’s metabolism to modify the
pathways but that methylcobalamine and folate can make a major difference to this. For a better explanation of this see page on
cobalamine.
Associations with other
sulphur molecules
Whiteley, P, Waring R, Shattock P, Hooper
M. Correlation of urinary exretion of cysteine – sulphate
metabolites and trans-indolyl-3-3acryloylglicine in 10 children diagnosed with
pervasive developmental disorders. Durham conference proceedings 2004. This shows a relationship between IAG and
urinary cysteine but with little else.
Waring R, Klovrza L. Sulphur metabolism in autism. J Nutr Envir Med 10;25-32
2000. (Ros Waring is particularly interested in cysteine
dioxidase as a limiting enzyme in the internal
production of sulphate. She realises
that the requirement of sulphate may be dramatically higher in autism than cysteine dioxidase can
supply).
Abnormal transmethylation/transsulfuration
metabolism and DNA hypomethylation among parents of
children with autism. James SJ, Melnyk
S, Jernigan S, Hubanks A, Rose S, Gaylor
DW. J Autism Dev Disord.
2008 Nov;38(10):1966-75. Epub 2008 May 30. Erratum
in: J Autism Dev Disord. 2008 Nov;38(10):1976. Jill
James, S. Recent evidence suggests that
some autistic children may have reduced detoxification capacity and may be
under chronic oxidative stress. Based on reports of abnormal methionine and glutathione metabolism in autistic children,
it was of interest to examine the same metabolic profile in the parents. The
results indicated that parents share similar metabolic deficits in methylation capacity and glutathione-dependent
antioxidant/detoxification capacity observed in many autistic children. At this point they had not found whether it
is due to a genetic change or not.
A mathematical model of glutathione
metabolism. Reed MC, Thomas RL, Pavisic
J, James SJ, Ulrich CM, Nijhout HF. Theor Biol Med Model. 2008 Apr
28;5:8. We show that the glutathione
pools in hepatic cells and in the blood are quite insensitive to fluctuations
in amino acid input and offer an explanation based on model predictions. In
contrast, we show that hepatic glutathione pools are highly sensitive to the
level of oxidative stress. The model shows that overexpression
of genes on chromosome 21 and an increase in oxidative stress can explain the
metabolic profile of Down syndrome. The model also correctly simulates the
metabolic profile of autism when oxidative stress is substantially increased
and the adenosine concentration is raised. Finally, we discuss how individual
variation arises and its consequences for one-carbon and glutathione
metabolism.
Glycosaminoglycans
These are
compounds as indicated as above with long chains of disaccharides (as shown),
possibly with molecular weights of over 5000.
They make up important parts of basal membranes and the borders between
tissues. The large amounts of sulphate on the surface of the molecules makes
them exceptionally soluble and interact precisely with sites on cells. They are not penetrable into the brain.
van der Kraan
PM, de Vries BJ, Vitters
EL, van den Berg WB, van de Putte LB. The effect of
low sulfate concentrations on the glycosaminoglycan
synthesis in anatomically intact articular cartilage
of the mouse. J Orthop
Res. 1989;7(5):645-53. (this would suggest that the relatively low sulphate
levels seen in autism may modify the glycosaminoglycans).
Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein
NJ. Disruption of sulphated glycosaminoglycans in
intestinal inflammation. Lancet 341:711–741, 1993. (although this has been demonstrated by Murch in other IBDs, all that
seems to have been shown in autism is that there is a thickening of the basal membrane in the
autistic gut biopsies and this has not been published)
Non sourced
data:
Sulphation low in 15 of 17 (mean 5 vs. nl
10-18) Glutathione Conjugation low in 14 of 17 (mean 0.55 vs
1.4-2.9) Glucuronidation
low in 17 of 17 (mean 9.6 vs. 26.0-46.0) Glycine
Conjugation low in 12 of 17 (15.4 vs. 30.0-53.0)
Return to home page